| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/01/2003 | CN1445237A Anagonism peptide of tumor necrosis factor and its application |
| 10/01/2003 | CN1122672C Process for preparing certain aza |
| 09/30/2003 | US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it |
| 09/30/2003 | US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
| 09/30/2003 | US6627609 Peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone- dependent tumours and |
| 09/30/2003 | US6627604 Memno peptides, process for their preparation and use thereof |
| 09/30/2003 | US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier |
| 09/25/2003 | WO2003079022A1 Ffluorescent reagent for selectively detecting double-stranded nucleic acid contianing fluorescent dye group and intercalate group |
| 09/25/2003 | WO2003079010A1 Fluorescent reagent cotanining fluorescent intercalator groups for detecting double-stranded nucleic acid |
| 09/25/2003 | WO2003078470A1 Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same |
| 09/25/2003 | WO2003078451A2 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 09/25/2003 | WO2003077872A2 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 09/25/2003 | WO2003006047A3 Methods for reducing immunogenicity of polypeptides |
| 09/25/2003 | WO2002085307A3 Glycopeptide antibiotics |
| 09/25/2003 | WO2002036161A3 Novel targeted compositions for diagnostic and therapeutic use |
| 09/25/2003 | WO2002028355A3 Methods and compositions for enhancing angiogenesis |
| 09/25/2003 | WO2002016411A3 Binding polypeptides and methods based thereon |
| 09/25/2003 | US20030181659 Thrombopoietin receptor modulating peptide |
| 09/25/2003 | US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire |
| 09/25/2003 | US20030181385 The LHRH antagonist comprise a peptide compound, wherein a residue of the peptide compound corresponding to the amino acid at position 6 of natural mammalian LHRH comprises a hydrophilic N- acyl moiety, a dipolar moiety, a sulfonium |
| 09/25/2003 | US20030181376 Control of crop pests & animal parasites through direct neuronal uptake |
| 09/25/2003 | US20030181370 H-Y antigen |
| 09/25/2003 | US20030181367 Membrane translocation peptides, compositions comprising them, chimeric molecules comprising them, and methods of using them to achieve transmembrane transport of various agents. |
| 09/25/2003 | US20030180884 Culturing a basidiomycete under low temperature and conditions such that it produces an antifreeze protein; high antifreeze activity such as a thermal hysteresis activity or an ice-recrystallizatin inhibition property |
| 09/25/2003 | US20030180805 Methods and compositions for derepression of IAP-inhibited caspase |
| 09/25/2003 | US20030180739 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence |
| 09/25/2003 | US20030180734 Peptide nucleic acids |
| 09/25/2003 | US20030180326 Methods and compositions for impairing multiplication of HIV-1 |
| 09/25/2003 | US20030180222 Using paramagnetic chelate peptide compound |
| 09/25/2003 | CA2478962A1 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 09/24/2003 | EP1346217A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 09/24/2003 | EP1345957A2 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 09/24/2003 | EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 09/24/2003 | EP1206482B1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 09/24/2003 | EP1123109B1 Contulakin-g, analogs thereof and uses therefor |
| 09/24/2003 | EP1094829B1 Methods for accelerating bone and cartilage growth and repair |
| 09/24/2003 | EP1049709B1 Antimicrobial peptides |
| 09/24/2003 | EP0785713B1 Creating an aerosolized formulation of insulin |
| 09/24/2003 | EP0723554B1 Cyclic peptide tube |
| 09/24/2003 | CN1444600A Use of ADNF polypeptides for enhancing learning and memory |
| 09/23/2003 | US6624290 Azapeptides useful in the treatment of Hepatitis C |
| 09/23/2003 | US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers |
| 09/23/2003 | US6624287 Method for searching physiologically active substances, process for producing these substances and drugs found by the searching method |
| 09/23/2003 | US6624144 Matrix metalloproteinase inhibitors and down-regulators |
| 09/23/2003 | US6624143 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/23/2003 | US6624142 Trimethyl lock based tetrapartate prodrugs |
| 09/23/2003 | US6624140 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 09/23/2003 | CA2139518C Antigenic regions of tlp complexes and antibodies against the same |
| 09/23/2003 | CA2113099C Differentiation of htlv-i and htlv-ii using synthetic peptides |
| 09/23/2003 | CA2112907C Peptide which abrogates tnf and/or lps toxicity |
| 09/23/2003 | CA2085781C Bradykinin-antagonists for the treatment of acute pancreatitis |
| 09/18/2003 | WO2003076621A2 Vpr modulators and uses thereof |
| 09/18/2003 | WO2003076460A1 A process for the production of ramoplanin-like amide derivatives |
| 09/18/2003 | WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 09/18/2003 | WO2003076391A2 Urokinase inhibitors, production and use thereof |
| 09/18/2003 | WO2003039454A8 Beta-secretase inhibitors and methods of use |
| 09/18/2003 | WO2002072614A3 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/18/2003 | WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 09/18/2003 | WO2002000687A9 Antimicrobial peptides and methods of use thereof |
| 09/18/2003 | WO2001072956A3 Compounds and methods for modulating desmosomal cadherin-mediated functions |
| 09/18/2003 | US20030176689 Inhibitors of hepatitis C virus protease |
| 09/18/2003 | US20030176656 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/18/2003 | US20030176641 Synthetic ion channels |
| 09/18/2003 | US20030176640 SGIP peptides |
| 09/18/2003 | US20030176354 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 09/18/2003 | US20030176352 Peptides and related compounds having thrombopoietic activity |
| 09/18/2003 | US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes |
| 09/18/2003 | US20030176337 Useful for inhibiting microbial infection or growth, as well reducing the effects of endotoxemia |
| 09/18/2003 | US20030176335 Surfactant peptide nanostructures, and uses thereof |
| 09/18/2003 | US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 09/18/2003 | US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/18/2003 | US20030175885 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/18/2003 | US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level |
| 09/18/2003 | US20030175799 Comprises stable amino acid sequence scaffold which mimics native protein structures and interactions; drug screening and design |
| 09/18/2003 | US20030175745 Peptides with growth inhibitory action |
| 09/18/2003 | US20030175285 Major histocompatibility complex ligands, comprising proteins, peptides, epitopes, polypeptides, mimetics or lipopeptides, used as vaccines |
| 09/18/2003 | US20030175280 Antagonists to chaperonin 10 |
| 09/18/2003 | US20030175252 Therapeutic compounds for ovarian cancer |
| 09/18/2003 | US20030175231 Contacting epidermal melanocytes with a peptide having amino acid sequence lysine-glycine- alanine to inhibit cell loss, which binds to p75 nerve growth factor receptor expressed on the surface of the melanocytes |
| 09/18/2003 | CA2477675A1 Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 09/18/2003 | CA2476567A1 A process for the production of ramoplanin-like amide derivatives |
| 09/17/2003 | EP1344827A2 Antifreeze proteins from basidiomycetes |
| 09/17/2003 | EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases |
| 09/17/2003 | EP1343819A1 Hla-a2.1 binding peptides and their uses |
| 09/17/2003 | EP1343811A1 Methods for preparing purified lipopeptides |
| 09/17/2003 | EP1343808A2 Process for the synthesis of a peptide having a trp residue |
| 09/17/2003 | EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 09/17/2003 | EP1343516A2 Analogues of thiocoraline and be-22179 |
| 09/17/2003 | EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region |
| 09/17/2003 | CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist |
| 09/17/2003 | CN1443195A LHRH-antagonists, production and use thereof as medicament |
| 09/17/2003 | CN1443079A Polymeric conjugates of antitumor agents |
| 09/17/2003 | CN1121413C Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/16/2003 | US6620911 Dolastatin 10 derivatives, of given formula; administering to infected human; useful as fungicides |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620419 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 09/16/2003 | US6620325 Purification process for cyclosporin |